• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Closed System Drug Transfer Device Market

    ID: MRFR/Pharma/11383-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Closed System Drug Transfer Device Market Research Report By Type (Membrane to Membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices) and By End-Users (Hospitals & Clinics, Specialty Centers, Others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Closed System Drug Transfer Device Market -Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Closed System Drug Transfer Device Market Summary

    The US Closed System Drug Transfer Device market is projected to experience substantial growth from 294 USD Million in 2024 to 3245 USD Million by 2035.

    Key Market Trends & Highlights

    US Closed System Drug Transfer Device Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 24.4% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3245 USD Million, indicating a robust expansion.
    • In 2024, the market is valued at 294 USD Million, reflecting the current demand for drug transfer solutions.
    • Growing adoption of closed system drug transfer devices due to increasing safety concerns in healthcare settings is a major market driver.

    Market Size & Forecast

    2024 Market Size 294 (USD Million)
    2035 Market Size 3245 (USD Million)
    CAGR (2025-2035) 24.4%

    Major Players

    Equashield, Vygon, MediPump, Baxter International, West Pharmaceutical Services, GrahamField Health Products, B. Braun Melsungen, PhaSeal, Medventive, ICU Medical, SafeMan, Vallon Pharmaceuticals, Corvida Medical, C3SB

    US Closed System Drug Transfer Device Market Trends

    The US Closed System Drug Transfer Device (CSTD) market is experiencing significant growth driven by the increasing awareness of drug safety and the need to minimize exposure to hazardous drugs among healthcare workers. Strict regulations set by the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH) are echoing the importance of using CSTDs in healthcare settings, thus propelling market demand.

    Additionally, the ongoing trend of improving aseptic practices and reducing the risk of contamination during drug preparation and administration is enhancing the adoption of these devices across hospitals and pharmacies in the US.

    Opportunities within the US market include the development of innovative, more user-friendly CSTDs that integrate advanced technology, potentially leading to improved efficiency and safety. Manufacturers are encouraged to explore partnerships with healthcare institutions to further educate practitioners on the benefits of CSTDs, ultimately increasing product uptake. Moreover, as healthcare systems continue to focus on patient-centric approaches, devices that offer enhanced safety features and ease of use are likely to see increased demand.

    Recent trends in the US indicate a growing preference for automated and electronic systems that streamline the drug transfer process. These systems can help reduce human error and improve healthcare outcomes, reflecting the ongoing transformation in the pharmaceutical delivery framework. Additionally, the push towards sustainable healthcare practices presents an opportunity for manufacturers to develop environmentally friendly packaging for CSTDs. The combination of these trends and drivers positions the US Closed System Drug Transfer Device market for substantial evolution and growth in the coming years.

    US Closed System Drug Transfer Device Market Drivers

    Market Segment Insights

    Closed System Drug Transfer Device Market Type Insights

    The US Closed System Drug Transfer Device Market is characterized by its diverse segmentation, particularly within the 'Type' category, which includes critical elements such as Membrane to Membrane and Needleless Systems. These device types play an essential role in enhancing safety and efficiency during drug transfer processes, especially in healthcare environments where contamination and exposure to hazardous materials pose significant risks. Membrane to Membrane systems are particularly notable for their ability to provide a secure and sterile environment, effectively minimizing the risk of drug leakage or aerosolization, which is a growing concern in the medical field.

    The importance of these systems is underscored by various regulatory guidelines that encourage their adoption to safeguard healthcare professionals and patients alike. On the other hand, Needleless Systems are gaining traction as they drastically reduce the need for needles, which leads to fewer needle-stick injuries and consequently enhances safety standards in medical settings. This is particularly significant in the US, where the Centers for Disease Control and Prevention (CDC) highlights the impact of needle-stick injuries on healthcare workers.

    The driving forces behind the increasing adoption of these device types include growth in the biopharmaceutical industry, a shift towards home healthcare settings, and rising regulatory frameworks aimed at improving occupational safety. Furthermore, the imperative to develop sophisticated drug delivery mechanisms to combat chronic diseases and ensure effective medication administration is pushing innovation in both these types of devices.

    Overall, the segmentation by 'Type' in the US Closed System Drug Transfer Device Market reveals vital insights into market dynamics, highlighting the crucial role of Membrane to Membrane and Needleless Systems in promoting safety and operational efficacy in drug handling and administration.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Closed System Drug Transfer Device Market Component Insights

    The US Closed System Drug Transfer Device Market is significantly driven by its Component segment, which includes essential categories such as Vial Access Devices, Syringe Safety Devices, Accessories, and Bag/Line Access Devices. These components play a crucial role in enhancing the safety and efficacy of drug transfer processes, thereby reducing the risk of contamination and exposure to hazardous drugs. Vial Access Devices are pivotal as they allow safe access to medication vials, ensuring sterility during the drug preparation phase. Similarly, Syringe Safety Devices are vital for minimizing needle-stick injuries among healthcare professionals, aligning with growing safety regulations across healthcare settings.

    Accessories complement the use of primary devices, while Bag/Line Access Devices contribute to the routing of medications without compromising safety standards. The increasing emphasis on patient safety, alongside advancements in technology, has led to a surge in demand for these devices in the US, further driving the evolution of the Closed System Drug Transfer Device Market. The focus on regulatory compliance and the need for efficient drug transfer systems to meet the healthcare industry's stringent safety requirements are expected to bolster growth in this segment, positioning it as a significant contributor to the overall market.

    Closed System Drug Transfer Device Market Closing Mechanism Insights

    The US Closed System Drug Transfer Device Market encompasses various crucial mechanisms, with the Closing Mechanism playing a pivotal role in ensuring safety and effectiveness in drug transfer processes. The Push to Turn System is recognized for its simplicity and reliability, making it a preferred choice among healthcare providers for preventing leakage and contamination. Similarly, the Color-to-color Alignment System enhances user confidence by providing visual cues for proper connection, thereby reducing the risk of errors during drug preparation.

    Leur Lock Systems are significant due to their versatility and compatibility with various syringes, which is essential in the fast-paced medical environment. Moreover, Click to Lock Systems are also emerging as popular options due to their intuitive design, which provides an audible confirmation of secure connections and assures healthcare professionals of a safe and leak-proof environment. Collectively, these mechanisms enhance the overall safety profile of drug transfer operations, addressing critical market needs amidst increasing regulations and rising awareness regarding drug safety and patient protection in the US healthcare landscape.

    The continuous improvements in these technologies signify a promising outlook for the US Closed System Drug Transfer Device Market.

    Closed System Drug Transfer Device Market Technology Insights

    The Technology segment of the US Closed System Drug Transfer Device Market focuses on various innovative solutions that enhance drug safety and protect healthcare personnel from hazardous drug exposure. Within this segment, Compartmentalize Devices are significant due to their design that prevents cross-contamination, thereby improving the handling of both hazardous and non-hazardous substances. Diaphragm-Based Devices stand out for their effective sealing mechanisms, which play a vital role in minimizing the risk of leakage during drug transfer processes.

    Furthermore, Air Filtration Devices are important in ensuring a sterile environment, mitigating exposure to airborne contaminants during drug handling. The integration of these technologies not only addresses safety concerns but also aligns with regulatory guidelines set forth by health authorities in the US. With the increasing focus on healthcare worker safety, the demand for these advanced solutions continues to rise, making the Technology segment a crucial component of the overall market landscape. The continuous evolution in technology and adherence to safety protocols highlight the significance and growth potential of these devices in safeguarding public health and improving clinical outcomes.

    Closed System Drug Transfer Device Market End-Users Insights

    The US Closed System Drug Transfer Device Market has a diverse array of End-Users, which plays a crucial role in the overall market dynamics. Hospitals and clinics represent a significant portion, as they serve as primary healthcare institutions where the administration of hazardous drugs is frequent, necessitating the usage of closed system drug transfer devices for ensuring safety and minimizing exposure risks. Specialty centers also hold considerable importance due to their focus on specific treatments that often involve high-risk medications, further driving the demand for safe drug transfer solutions in these settings.

    The growing awareness of safety protocols and regulatory guidelines in the treatment of patients is propelling the adoption of closed system drug transfer devices across these End-Users. Meanwhile, other entities also contribute to the market by utilizing these devices to ensure compliance with safety standards and enhance operational efficiencies, reflecting a comprehensive approach to care across different healthcare environments. This segmentation highlights the varied applications and needs of each End-User, underscoring their importance in shaping the market landscape.

    Get more detailed insights about US Closed System Drug Transfer Device Market -Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The US Closed System Drug Transfer Device Market is characterized by a rapidly evolving landscape driven by increasing awareness regarding the safety of chemotherapy handling and management. This market consists of devices designed to mitigate risks associated with hazardous drug exposure among healthcare professionals and patients. A growing emphasis on occupational safety, coupled with stringent regulatory measures, has accelerated the adoption of closed system drug transfer devices (CSTD) across healthcare settings. Competitive dynamics within the market involve a blend of well-established players and emerging companies striving to innovate and capture market share.

    Companies engage in strategic partnerships, product development, and marketing campaigns that aim to highlight the efficacy and safety of their devices, positioning themselves as leaders in this essential market.

    Equashield

    Equashield is a notable player in the US Closed System Drug Transfer Device Market, focusing on the development and distribution of innovative solutions that ensure the safe handling of hazardous drugs. The company's primary strength lies in its ability to provide a comprehensive and integrated system that not only minimizes exposure risk but also enhances operational efficiency in healthcare settings. Equashield's presence in the US is marked by a robust network of healthcare partnerships, which facilitates the distribution of its products to a wide range of customer segments, including hospitals, oncology clinics, and other specialized healthcare facilities.

    By continually advancing its technology and maintaining a strong commitment to quality and safety, Equashield has carved a significant niche in the market that emphasizes both performance and reliability.

    Vygon

    Vygon, another key entity in the US Closed System Drug Transfer Device Market, specializes in comprehensive medical supply solutions that cater to healthcare professionals. The company offers a range of innovative products, including closed system drug transfer devices, designed to protect healthcare workers and patients from the dangers posed by hazardous drugs. Vygon's strengths lie in its extensive market presence and its dedication to quality, underpinned by a commitment to research and development. This ensures a consistent flow of innovative solutions tailored to the evolving needs of healthcare providers in the US.

    The company has also engaged in strategic mergers and acquisitions to expand its product portfolio and enhance its market presence, solidifying its position as a trusted supplier for healthcare settings looking for safe and effective drug transfer solutions. Vygon's ability to recognize and adapt to market demands has further enhanced its reputation, contributing to its competitive edge in the US market.

    Key Companies in the US Closed System Drug Transfer Device Market market include

    Industry Developments

    The US Closed System Drug Transfer Device Market is witnessing significant developments as of late 2023. The demand for safer drug handling in healthcare settings is escalating due to increasing regulatory scrutiny and a heightened focus on patient safety. Companies like Baxter International and ICU Medical are expanding their product offerings to meet these requirements. In recent competitive moves, West Pharmaceutical Services is developing innovative solutions to enhance drug delivery efficacy. 

    In terms of mergers and acquisitions, Equashield announced a strategic acquisition of a smaller biotech firm focused on improving drug transfer technologies in October 2023, while B. Braun Melsungen completed the acquisition of a niche manufacturer to fortify its market presence in August 2023. The market continues to grow, driven by technological advancements and a 15% increase in market valuation noted from 2021 to 2023. Furthermore, ongoing regulatory updates from the FDA aim to bolster safety standards for closed drug transfer systems.

    With the industry's focus on reducing the risk of exposure to hazardous drugs, manufacturers are prioritizing Research and Development to innovate safer solutions for healthcare providers.

    Market Segmentation

    Closed System Drug Transfer Device Market Type Outlook

    • Membrane to Membrane
    • Needleless System

    Closed System Drug Transfer Device Market Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Accessories
    • Bag/Line Access Devices

    Closed System Drug Transfer Device Market End-Users Outlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Closed System Drug Transfer Device Market Closing Mechanism Outlook

    • Push to Turn System
    • Color-to-color Alignment System
    • Leur Lock Systems
    • Click to Lock Systems

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 262.15(USD Million)
    MARKET SIZE 2024 294.0(USD Million)
    MARKET SIZE 2035 3245.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 24.396% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Equashield, Vygon, MediPump, Baxter International, West Pharmaceutical Services, GrahamField Health Products, B. Braun Melsungen, PhaSeal, Medventive, ICU Medical, SafeMan, Vallon Pharmaceuticals, Corvida Medical, C3S, BD
    SEGMENTS COVERED Type, Component, Closing Mechanism, Technology, End-Users
    KEY MARKET OPPORTUNITIES Rising demand for safety regulations, Increasing chemotherapy drug usage, Growing awareness of hazardous drug handling, Technological advancements in device design, Expansion in home healthcare settings
    KEY MARKET DYNAMICS Increasing adoption of safety protocols, Rising awareness of drug contamination, Regulatory compliance and approval requirements, Growing emphasis on healthcare worker safety, Technological advancements in device design
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the expected market size of the US Closed System Drug Transfer Device Market in 2024?

    The expected market size of the US Closed System Drug Transfer Device Market in 2024 is valued at 294.0 million USD.

    What is the projected market size for the US Closed System Drug Transfer Device Market by 2035?

    By 2035, the projected market size for the US Closed System Drug Transfer Device Market is estimated to reach 3245.0 million USD.

    What is the expected CAGR for the US Closed System Drug Transfer Device Market from 2025 to 2035?

    The expected CAGR for the US Closed System Drug Transfer Device Market from 2025 to 2035 is 24.396 percent.

    Which companies are the key players in the US Closed System Drug Transfer Device Market?

    Key players in the market include Equashield, Vygon, MediPump, Baxter International, and West Pharmaceutical Services among others.

    What will be the market value for Membrane to Membrane devices in 2035?

    The market value for Membrane to Membrane devices is projected to be 1500.0 million USD by 2035.

    What is the market size of Needleless Systems in 2024?

    The market size of Needleless Systems in 2024 is expected to be 164.0 million USD.

    What will be the estimated market value for Needleless Systems by 2035?

    By 2035, the estimated market value for Needleless Systems is anticipated to reach 1745.0 million USD.

    What are the growth drivers for the US Closed System Drug Transfer Device Market?

    Growth drivers for the market include increasing awareness of safety measures and technological advancements in drug transfer systems.

    What challenges might the US Closed System Drug Transfer Device Market face in the coming years?

    The market may face challenges including regulatory hurdles and the need for ongoing product innovations.

    Which segment is expected to have the largest market share in the US Closed System Drug Transfer Device Market?

    The Membrane to Membrane segment is expected to have a significant share of the market by 2035 compared to other segments.

    What is the expected market size for the US Closed System Drug Transfer Device Market in 2024?

    The US Closed System Drug Transfer Device Market is expected to be valued at 294.0 million USD in 2024.

    What is the projected market value for the US Closed System Drug Transfer Device Market by 2035?

    The market is projected to reach a value of 3249.88 million USD by 2035.

    Which type of Closed System Drug Transfer Device is expected to hold a significant market share by 2035?

    The Membrane to Membrane type is expected to hold a significant market share, valued at 1857.45 million USD by 2035.

    What is the anticipated market value of the Needleless System segment in 2035?

    The Needleless System segment is anticipated to be valued at 1392.43 million USD by 2035.

    Who are some of the major players in the US Closed System Drug Transfer Device Market?

    Major players in the market include Equashield, Terumo Medical Corporation, Medtronic, and Becton Dickinson and Company.

    How is the growth rate for the US Closed System Drug Transfer Device Market expected to vary regionally?

    The growth rate is expected to vary regionally, reflecting the demand and adoption in various healthcare facilities across the US.

    What key applications drive the growth of the US Closed System Drug Transfer Device Market?

    The key applications driving market growth include oncology and hazardous drug handling in healthcare settings.

    What are the emerging trends influencing the US Closed System Drug Transfer Device Market?

    Emerging trends include increased safety standards and advancements in product design aimed at minimizing drug exposure for healthcare workers.

    What challenges may affect the growth of the US Closed System Drug Transfer Device Market?

    Challenges such as regulatory hurdles and the need for extensive training may affect market growth.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. US
    59. Closed System Drug Transfer Device Market, BY Type (USD Million)
    60. Membrane
    61. to Membrane
    62. Needleless System
    63. US
    64. Closed System Drug Transfer Device Market, BY Component (USD Million)
    65. Vial
    66. Access Devices
    67. Syringe Safety Devices
    68. Accessories
    69. Bag/Line
    70. Access Devices
    71. US Closed System
    72. Drug Transfer Device Market, BY Closing Mechanism (USD Million)
    73. Push
    74. to Turn System
    75. Color-to-color Alignment System
    76. Leur
    77. Lock Systems
    78. Click to Lock Systems
    79. US
    80. Closed System Drug Transfer Device Market, BY Technology (USD Million)
    81. Compartmentalize
    82. Devices
    83. Diaphragm-Based Devices
    84. Air
    85. Filtration Devices
    86. US Closed
    87. System Drug Transfer Device Market, BY End-Users (USD Million)
    88. Hospitals
    89. & Clinics
    90. Specialty Centers
    91. Others
    92. Competitive Landscape
    93. Overview
    94. Competitive
    95. Analysis
    96. Market share Analysis
    97. Major
    98. Growth Strategy in the Closed System Drug Transfer Device Market
    99. Competitive
    100. Benchmarking
    101. Leading Players in Terms of Number of Developments
    102. in the Closed System Drug Transfer Device Market
    103. Key
    104. developments and growth strategies
    105. New Product Launch/Service
    106. Deployment
    107. Merger & Acquisitions
    108. Joint
    109. Ventures
    110. Major Players Financial Matrix
    111. Sales
    112. and Operating Income
    113. Major Players R&D Expenditure.
    114. Company
    115. Profiles
    116. Equashield
    117. Financial
    118. Overview
    119. Products Offered
    120. Key
    121. Developments
    122. SWOT Analysis
    123. Key
    124. Strategies
    125. Vygon
    126. Financial
    127. Overview
    128. Products Offered
    129. Key
    130. Developments
    131. SWOT Analysis
    132. Key
    133. Strategies
    134. MediPump
    135. Financial
    136. Overview
    137. Products Offered
    138. Key
    139. Developments
    140. SWOT Analysis
    141. Key
    142. Strategies
    143. Baxter International
    144. Financial
    145. Overview
    146. Products Offered
    147. Key
    148. Developments
    149. SWOT Analysis
    150. Key
    151. Strategies
    152. West Pharmaceutical Services
    153. Financial
    154. Overview
    155. Products Offered
    156. Key
    157. Developments
    158. SWOT Analysis
    159. Key
    160. Strategies
    161. GrahamField Health Products
    162. Financial
    163. Overview
    164. Products Offered
    165. Key
    166. Developments
    167. SWOT Analysis
    168. Key
    169. Strategies
    170. B. Braun Melsungen
    171. Financial
    172. Overview
    173. Products Offered
    174. Key
    175. Developments
    176. SWOT Analysis
    177. Key
    178. Strategies
    179. PhaSeal
    180. Financial
    181. Overview
    182. Products Offered
    183. Key
    184. Developments
    185. SWOT Analysis
    186. Key
    187. Strategies
    188. Medventive
    189. Financial
    190. Overview
    191. Products Offered
    192. Key
    193. Developments
    194. SWOT Analysis
    195. Key
    196. Strategies
    197. ICU Medical
    198. Financial
    199. Overview
    200. Products Offered
    201. Key
    202. Developments
    203. SWOT Analysis
    204. Key
    205. Strategies
    206. SafeMan
    207. Financial
    208. Overview
    209. Products Offered
    210. Key
    211. Developments
    212. SWOT Analysis
    213. Key
    214. Strategies
    215. Vallon Pharmaceuticals
    216. Financial
    217. Overview
    218. Products Offered
    219. Key
    220. Developments
    221. SWOT Analysis
    222. Key
    223. Strategies
    224. Corvida Medical
    225. Financial
    226. Overview
    227. Products Offered
    228. Key
    229. Developments
    230. SWOT Analysis
    231. Key
    232. Strategies
    233. C3S
    234. Financial
    235. Overview
    236. Products Offered
    237. Key
    238. Developments
    239. SWOT Analysis
    240. Key
    241. Strategies
    242. BD
    243. Financial
    244. Overview
    245. Products Offered
    246. Key
    247. Developments
    248. SWOT Analysis
    249. Key
    250. Strategies
    251. References
    252. Related
    253. Reports
    254. LIST
    255. OF ASSUMPTIONS
    256. US Closed System Drug Transfer Device
    257. Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    258. US
    259. Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY COMPONENT,
    260. 2035 (USD Billions)
    261. US Closed System Drug Transfer
    262. Device Market SIZE ESTIMATES & FORECAST, BY CLOSING MECHANISM, 2019-2035 (USD
    263. Billions)
    264. US Closed System Drug Transfer Device Market
    265. SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    266. US
    267. Closed System Drug Transfer Device Market SIZE ESTIMATES & FORECAST, BY END-USERS,
    268. 2035 (USD Billions)
    269. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    270. ACQUISITION/PARTNERSHIP
    271. LIST
    272. Of figures
    273. MARKET SYNOPSIS
    274. US
    275. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TYPE
    276. US
    277. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY COMPONENT
    278. US
    279. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY CLOSING MECHANISM
    280. US
    281. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY TECHNOLOGY
    282. US
    283. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET ANALYSIS BY END-USERS
    284. KEY
    285. BUYING CRITERIA OF CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    286. RESEARCH
    287. PROCESS OF MRFR
    288. DRO ANALYSIS OF CLOSED SYSTEM DRUG TRANSFER
    289. DEVICE MARKET
    290. DRIVERS IMPACT ANALYSIS: CLOSED SYSTEM
    291. DRUG TRANSFER DEVICE MARKET
    292. RESTRAINTS IMPACT ANALYSIS:
    293. CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    294. SUPPLY / VALUE
    295. CHAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET
    296. CLOSED
    297. SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2025 (% SHARE)
    298. CLOSED
    299. SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    300. CLOSED
    301. SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2025 (% SHARE)
    302. CLOSED
    303. SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019 TO 2035 (USD Billions)
    304. CLOSED
    305. SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2025 (% SHARE)
    306. CLOSED
    307. SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019 TO 2035 (USD Billions)
    308. CLOSED
    309. SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    310. CLOSED
    311. SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    312. CLOSED
    313. SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2025 (% SHARE)
    314. CLOSED
    315. SYSTEM DRUG TRANSFER DEVICE MARKET, BY END-USERS, 2019 TO 2035 (USD Billions)
    316. BENCHMARKING
    317. OF MAJOR COMPETITORS

    US Closed System Drug Transfer Device Market Segmentation

    • Closed System Drug Transfer Device Market By Type (USD Million, 2019-2035)

      • Membrane to Membrane
      • Needleless System
    • Closed System Drug Transfer Device Market By Component (USD Million, 2019-2035)

      • Vial Access Devices
      • Syringe Safety Devices
      • Accessories
      • Bag/Line Access Devices
    • Closed System Drug Transfer Device Market By Closing Mechanism (USD Million, 2019-2035)

      • Push to Turn System
      • Color-to-color Alignment System
      • Leur Lock Systems
      • Click to Lock Systems
    • Closed System Drug Transfer Device Market By Technology (USD Million, 2019-2035)

      • Compartmentalize Devices
      • Diaphragm-Based Devices
      • Air Filtration Devices
    • Closed System Drug Transfer Device Market By End-Users (USD Million, 2019-2035)

      • Hospitals & Clinics
      • Specialty Centers
      • Others
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials